Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Recording of ’COVID-19 vaccine declined‘: a cohort study on 57.9 million National Health Service patients’ records in situ using OpenSAFELY, England, 8 December 2020 to 25 May 2021

Curtis HJ. et al, (2022), Eurosurveillance, 27

Incidence and management of inflammatory arthritis in England before and during the COVID-19 pandemic: a population-level cohort study using OpenSAFELY

Russell MD. et al, (2022)

Association between household composition and severe COVID-19 outcomes in older people by ethnicity: an observational cohort study using the OpenSAFELY platform.

Wing K. et al, (2022), Int J Epidemiol

A hypothesis-free data science approach to identifying novel patterns of clinical interest in clinicians' treatment preferences: clusters of high Pericyazine and Promazine use in England (Preprint)

MacKenna B. et al, (2022)

Comparative effectiveness of BNT162b2 versus mRNA-1273 boosting in England: a cohort study in OpenSAFELY-TPP

Hulme W. et al, (2022)

Comparative effectiveness of ChAdOx1 versus BNT162b2 covid-19 vaccines in health and social care workers in England: cohort study using OpenSAFELY.

Hulme WJ. et al, (2022), BMJ, 378

Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records.

Horne EMF. et al, (2022), BMJ, 378

The impact of COVID-19 on prescribing of pancreatic enzyme replacement therapy for people with unresectable pancreatic cancer in England. A cohort study using OpenSafely-TPP

Lemanska A. et al, (2022)

OpenSAFELY: Representativeness of Electronic Health Record platform OpenSAFELY-TPP data compared to the population of England

Andrews C. et al, (2022)

Factors associated with COVID-19 vaccine uptake in people with kidney disease: an OpenSAFELY cohort study

The OpenSAFELY Collaborative None. et al, (2022)

Effectiveness of BNT162b2 booster doses in England: an observational study in OpenSAFELY-TPP

Hulme WJ. et al, (2022)

OpenSAFELY NHS Service Restoration Observatory 2: changes in primary care activity across six clinical areas during the COVID-19 pandemic

Curtis H. et al, (2022)

Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe COVID-19 outcomes in non-hospitalised patients: an observational cohort study using the OpenSAFELY platform

Zheng B. et al, (2022)

Changes in English medication safety indicators throughout the COVID-19 pandemic: a federated analysis of 57 million patients’ primary care records in situ using OpenSAFELY

Fisher L. et al, (2022)

Using data science to identify unusual treatment choices in England: illustrative findings of uncommon antipsychotics Pericyazine and Promazine

MacKenna B. et al, (2022)

Waning effectiveness of BNT162b2 and ChAdOx1 COVID-19 vaccines over six months since second dose: a cohort study using linked electronic health records

Horne EMF. et al, (2022)

Trends, regional variation and clinical characteristics of recipients of antivirals and neutralising monoclonal antibodies for non-hospitalised COVID-19: a descriptive cohort study of 23.4 million people in OpenSAFELY

Green A. et al, (2022)

Potentially inappropriate prescribing of DOACs to people with mechanical heart valves: A federated analysis of 57.9 million patients' primary care records in situ using OpenSAFELY

Fisher L. et al, (2022), Thrombosis Research, 211, 150 - 153

Comparison of methods for predicting COVID-19-related death in the general population using the OpenSAFELY platform.

OpenSAFELY Collaborative None. et al, (2022), Diagn Progn Res, 6

Sales of Over-the-Counter Products Containing Codeine in 31 Countries, 2013-2019: A Retrospective Observational Study.

Richards GC. et al, (2022), Drug Saf

Load More

1
2
3
4
5
6
7
...
»